May 19, 2016 — Leeds Cancer Centre, one of the largest providers of cancer care in the U.K., will upgrade its existing treatment equipment with eight Elekta Versa HD linear accelerators.
Viv Cosgrove, Ph.D., head of radiotherapy physics at Leeds Cancer Centre, said, “The new linear accelerators are able to deliver improvements in treatment accuracy for patients. This will help us increase the use of high-dose radiation treatments such as stereotactic body radiotherapy. These treatments reduce the total number of patient visits whilst improving clinical effectiveness.
“The replacement of the existing equipment also allows us to create a very advanced platform for increasing our research and innovation programs, all of which directly benefit patients in the form of clinical trials and research initiatives.”
The Versa HD linear accelerators will include Agility multileaf collimators. These, combined with volumetric modulated arc therapy (VMAT) delivery, could enable clinicians at Leeds Cancer Centre to deliver complex head and neck plans up to 42 percent faster.
The deal was facilitated by Medipass, a leading European managed equipment services company, which partners with hospitals to manage efficient medical equipment solutions.
Seven of the eight linear accelerators were booked during the fourth quarter of Elekta’s fiscal year 2015-16.
For more information: www.elekta.com
March 28, 2024 
